Yu L X, Amidon G L
Glaxo Wellcome Inc., Five Moore Drive, Research Triangle Park, NC 27709, USA.
Int J Pharm. 1999 Sep 20;186(2):119-25. doi: 10.1016/s0378-5173(99)00147-7.
This report describes a compartmental absorption and transit model to estimate the fraction of dose absorbed and the rate of drug absorption for passively transported drugs in immediate release products. The model considers simultaneous small intestinal transit flow and drug absorption. Both analytical and numerical methods were utilized to solve the model equations. It was found that the fraction of dose absorbed can be estimated by F(a) = 1-(1+0.54 P(eff))(-7), where P(eff) is the human effective permeability in cm/h. A good correlation was found between the fraction of dose absorbed and the effective permeability for ten drugs covering a wide range of absorption characteristics. The model was able to explain the oral plasma concentration profiles of atenolol.
本报告描述了一种房室吸收和转运模型,用于估计速释产品中被动转运药物的吸收剂量分数和药物吸收速率。该模型考虑了小肠同时的转运流和药物吸收。采用解析法和数值法求解模型方程。结果发现,吸收剂量分数可通过F(a)=1-(1 + 0.54P(eff))^(-7)来估计,其中P(eff)是以厘米/小时为单位的人体有效渗透率。在涵盖广泛吸收特性的十种药物的吸收剂量分数与有效渗透率之间发现了良好的相关性。该模型能够解释阿替洛尔的口服血浆浓度曲线。